🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to assess the effect of gefitinib on...
Status
Unknown
Location
Sun Yat-Sen Univercity Cancer Center
Start Date
2020-05-26
Trial ID
NCT04390984
Treatments Being Tested
Apatinib plus XELOX regime as Neoadjuvant Therapy in Locally Advanced Gastr...
Status
Unknown
Location
ZhongShan hospital FuDan university
Start Date
2017-02-01
Trial ID
NCT03229096
Treatments Being Tested
The hypothesis of this clinical research study is to discover if the study ...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2011-11
Trial ID
NCT01653561
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and toxicity of apatin...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2016-08-10
Trial ID
NCT02867956
This study evaluated the tolerance, safety and efficacy of Apatinib plus Do...
Status
Unknown
Location
Sir Run Run Shaw Hospital
Start Date
2015-10
Trial ID
NCT03071042
Apatinib second line treatment for Advanced osteosarcoma and soft tissue sa...
Status
Unknown
Location
Henan cancer hospital
Start Date
2017-04-11
Trial ID
NCT03163381
Treatments Being Tested
We conduct the clinical trial to further explore the efficacy and safety of...
Status
Unknown
Location
First Affiliated Hospital of Anhui Medical University
Start Date
2017-03-23
Trial ID
NCT03224221
Treatments Being Tested
This study will focus on postoperative patients of stage IIIB or stage IIIC...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2018-02-12
Trial ID
NCT03365765
Treatments Being Tested
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients Wit...
Status
Unknown
Location
Multiple Locations
Start Date
2018-06-01
Trial ID
NCT03547375
Treatments Being Tested
Gastric cancer is a highly heterogeneous tumor. The most commonly used clin...
Status
Withdrawn
Location
Beijing Cancer Hospital / Peking University Cancer Hospital
Start Date
2021-05-11
Trial ID
NCT04863430
Treatments Being Tested